Evidence map›Paper›PMID 39858581›Full record

ReviewGenes2024

Snowflake Data Warehouse for Large-Scale and Diverse Biological Data Management and Analysis.

Tatsuya Koreeda, Hiroshi Honda, Jun-Ichi Onami

Abstract readReview
In one paragraph

Review in Genes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tatsuya KoreedaCLINIC FOR Group, Nagisa Terrace 4F, 3-1-32 Shibaura, Minato-ku, Tokyo 108-0023, Japan.ORCID 0009-0002-8271-2003
Hiroshi HondaKao Corporation, Bunka, Sumida-ku, Tokyo 131-8501, Japan.ORCID 0000-0002-2936-2617
Jun-Ichi OnamiRIKEN BioResource Research Center, 3-1-1 Koyadai, Tsukuba 305-0074, Japan.ORCID 0000-0003-0790-8313

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the increasing speed of genomic, transcriptomic, and metagenomic data generation driven by the advancement and widespread adoption of next-generation sequencing technologies, the management and analysis of large-scale, diverse data in the fields of life science and biotechnology have become critical challenges. In this paper, we thoroughly discuss the use of cloud data warehouses to address these challenges. Specifically, we propose a data management and analysis framework using Snowflake, a SaaS-based data platform. We further demonstrate its convenience and effectiveness through concrete examples, such as disease variant analysis and in silico drug discovery. By introducing Snowflake, researchers can efficiently manage and analyze a wide array of biological data, enabling the discovery of new biological insights through integrated analysis. Through these specific methodologies and application examples, we aim to accelerate research progress in the field of bioinformatics.

Indexed as

Computational BiologyDatabase Management SystemsCloud ComputingDrug DiscoveryGenomicsHigh-Throughput Nucleotide SequencingHumansSoftwarebig databiodatabioinformaticsdata sciencedata warehouseSnowflake

Identifiers

PMID39858581
PMCPMC11765040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.